In this edition of “Sharma’s Endoscopy Insights,” I highlight two studies related to resection—an approach to ulcerative colitis–related lesions and…
Browsing: Clinical Updates
NEW YORK, Sept. 7, 2023 /PRNewswire/ — Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary…
A recent clinical trial has indicated that using resistant starch as a microbiota-directed dietary supplement could be a promising intervention…
The article delves into the potential of fecal microbiota transplantation (FMT) as a treatment for ulcerative colitis (UC). A comprehensive…
A comprehensive review and meta-analysis of 25 studies, involving approximately 30,000 adults, revealed that behavioral interventions can significantly enhance colonoscopy…
While the overall incidence of cancer in the U.S. has decreased, liver cancer has seen a 48% increase since 2000.…
The research delves into the varying sedation techniques employed during the double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) procedure, a topic of…
ISA Pharmaceuticals announced that the first patient has been treated in its first-in-human phase 1 trial of its novel immunotherapeutic…
Early detection is crucial for effective cancer treatment, and liquid biopsies, which involve a simple blood draw, are emerging as…
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. Researchers from Helmholtz Munich and the University of…